Ephraim Resources Limited Share Price

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote 04:47:55 28/02/2017 GMT 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -

Valuation: Ephraim Resources Limited

Market Cap 3.08M 2.74M 2.54M 2.31M 4.35M 292M 4.44M 30.48M 11.97M 152M 11.56M 11.31M 487M P/E 2017
-6.41x
P/E 2018 -3.16x
Enterprise Value 3.63M 3.23M 2.99M 2.72M 5.13M 345M 5.23M 35.91M 14.1M 180M 13.62M 13.33M 573M EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 27/01/2020
Director TitleAgeSince
Director/Board Member 60 16/01/2020
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 2.09M
-6.60%-10.93%+45.08%+60.01% 68.98B
-4.09%+3.12%+3.71%+53.50% 53.15B
+0.03%+7.21%+12.52%+44.46% 50.83B
-1.53%+3.10%+31.40%+33.88% 44.61B
-5.97%-5.40%+259.08%+494.98% 40.57B
-1.34%+5.41%+16.74%+106.42% 42.53B
+6.53%+8.02%+18.98%+54.58% 30.95B
-0.90%-10.91%+34.11%-1.83% 25.44B
-2.76%-4.73%-15.94%-15.32% 22.66B
Average +8.52%+11.37%+45.08%+92.30% 37.97B
Weighted average by Cap. -2.32%+1.65%+46.51%+96.53%

Financials

2017 2018
Net sales 16.01K 14.24K 13.19K 12.01K 22.63K 1.52M 23.06K 158K 62.2K 793K 60.08K 58.8K 2.53M 124 110.33 102.13 93.04 175.3 11.77K 178.57 1.23K 481.76 6.14K 465.31 455.4 19.59K
Net income -481K -428K -396K -361K -680K -45.67M -693K -4.76M -1.87M -23.81M -1.8M -1.77M -75.98M -976K -868K -803K -732K -1.38M -92.63M -1.4M -9.66M -3.79M -48.3M -3.66M -3.58M -154M
Net Debt 497K 442K 409K 373K 702K 47.16M 715K 4.92M 1.93M 24.59M 1.86M 1.82M 78.48M 548K 488K 452K 411K 775K 52.06M 790K 5.43M 2.13M 27.15M 2.06M 2.01M 86.63M
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-